Massimo Cristofanilli, M.D. is the Scientific Director of the EIPM.
In early 2022, Dr. Massimo Cristofanilli joined the Englander Institute as Scientific Director. With experience as Associate Director of Translational Research and Precision Medicine at Northwestern Medicine, Dr. Cristofanilli is an expert in the translational research and treatment of patients with inflammatory breast cancer, and has led the development of novel diagnostic and prognostic markers in primary and metastatic breast cancer. His research is focused on advancing a patient-centered, biology-driven model of cancer care, combining sophisticated tissue and blood- based molecular diagnostic technologies and innovative treatments.